Evidence map›Paper›PMID 30250978›Full record

ArticleApplied microbiology and biotechnology2018

Functional expression of monomeric streptavidin and fusion proteins in Escherichia coli: applications in flow cytometry and ELISA.

Andrew Kroetsch, Brandon Chin, Vyncent Nguyen, Jingyuan Gao, Sheldon Park

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Andrew Kroetsch *Department of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Brandon Chin *Department of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Vyncent NguyenDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Jingyuan GaoDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Sheldon ParkDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA. sjpark6@buffalo.edu.ORCID http://orcid.org/0000-0002-3831-000X
University at Buffalo, State University of New York · USAlbany Molecular Research (United States) · USSage Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monomeric streptavidin (mSA) offers a combination of structural and binding properties that are useful in many applications, including a small size and monovalent biotin binding. Because mSA contains a structurally important disulfide bond, the molecule does not fold correctly when expressed inside the cell. We show that mSA can be expressed in a functional form in Escherichia coli by fusing the OmpA signal sequence at the amino terminus. Expressed mSA is exported to the periplasm, from which the molecule leaks to the medium under vigorous shaking. Purified mSA can be conjugated with FITC and used to label microbeads and yeast cells for analysis by flow cytometry, further expanding the scope of mSA-based applications. Some applications require recombinant fusion of mSA with another protein. mSA fused to EGFP cannot be secreted to the medium but was successfully expressed in an engineered cell line that supports oxidative folding in the cytoplasm. Purified mSA-EGFP and mSA-mCherry bound biotin with high affinity and were successfully used in conventional flow cytometry and imaging flow cytometry. Finally, we demonstrate the use of mSA in ELISA, in which horseradish peroxidase-conjugated mSA and biotinylated secondary antibody are used together to detect primary antibody captured on an ELISA plate. Engineering mSA to introduce additional lysine residues can increase the reporter signal above that of wild-type streptavidin. Together, these examples establish mSA as a convenient reagent with a potentially unique role in biotechnology.

Indexed as

Bacterial Outer Membrane ProteinsBacterial ProteinsBinding SitesBiotinBiotinylationEnzyme-Linked Immunosorbent AssayEscherichia coliFlow CytometryGene Expression Regulation, BacterialHorseradish PeroxidaseRecombinant Fusion ProteinsStreptavidinBacterial Outer Membrane ProteinsBacterial ProteinsBiotinHorseradish PeroxidaseOMPA outer membrane proteinsRecombinant Fusion ProteinsStrep-avidin conjugated horseradish peroxidaseStreptavidinELISAFlow cytometryProtein purificationSecretionStreptavidin

Identifiers

PMID30250978
OpenAlexW2894368182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.